Rachel Rankin
Nurse Practitioner · New York, NYNPI 1891447595
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 463 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,937, 8.1 times the $488 reported in 2022. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 463 payments — averaging $22.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$1K
- Sanofi$1K
- Pfizer$979
- Incyte Corporation$747
- Regeneron Healthcare Solutions, Inc.$688
- plus $3K from 15 others
What the payments were for
- Food & beverage$9,88495%
- Education$4745%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $2,272 |
| UCB, Inc. | 56 | $1,205 |
| Sanofi | 33 | $1,010 |
| Pfizer | 54 | $979 |
| Incyte Corporation | 35 | $747 |
| Regeneron Healthcare Solutions, Inc. | 25 | $688 |
| LEO Pharma Inc. | 46 | $537 |
| Arcutis Biotherapeutics, Inc. | 31 | $497 |
| Lilly USA, LLC | 16 | $462 |
| Johnson & Johnson | 12 | $454 |
| Sun Pharmaceutical Industries Inc. | 15 | $324 |
| Novartis | 17 | $305 |
| Galderma Laboratories, L.p. | 14 | $247 |
| E.r. Squibb & Sons, L.L.C. | 7 | $161 |
| Verrica Pharmaceuticals Inc. | 1 | $124 |
| Amgen | 4 | $93 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Dermavant Sciences, Inc. | 4 | $82 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $44 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,358 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpzeluraRuxolitinib Phosphate | 18 | $34,550 |
| Tacrolimus | 33 | $6,728 |
| Tretinoin | 40 | $1,816 |
| Fluocinonide | 26 | $1,361 |
| Betamethasone Dipropionate | 19 | $961 |
| Ketoconazole | 61 | $824 |
| Clobetasol Propionate | 11 | $619 |
| Ammonium Lactate | 24 | $452 |
| Clotrimazole | 11 | $366 |
| Ciclopirox | 14 | $352 |
| Triamcinolone Acetonide | 36 | $325 |
| Doxycycline Hyclate | 13 | $123 |
| Spironolactone | 11 | $91 |
| Hydrocortisone | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Incyte CorporationOpzelura | $747 | $34,55018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in New York
- Patricia McGoldrickNew York$202K
- Jodi LogerfoNew York$48K
- Aileen FerrickNew York$26K
- Tsz Isabel WongNew York$25K
- Chris BustamanteNew York$22K
- Mayra PozoNew York$14K
- Janet JohnsonNew York$12K
- Richelle CassellNew York$10K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.